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Abstract
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Background—Carotid plaque MRI has been a useful method to characterize vulnerable
atherosclerotic plaque elements. Recent investigations have suggested that source images from CT
angiography (CTA) and MR angiography (MRA) can identify the simple high-risk features of
symptom-producing carotid artery plaque. We studied the correlation and relative diagnostic
accuracies of CTA and MRA source images in detecting symptomatic carotid artery plaque.
Methods—Subjects were eligible if they had carotid stenosis between 50 and 99% and had MRA
and CTA exams performed within 10 days of one another. We measured the soft (non-calcified)
plaque and hard (calcified) plaque thickness on CTA axial source images and intraplaque highintensity signal (IHIS) on 3D-time-of-flight MRA source images in subjects. We assessed whether
a correlation existed between increasing CTA soft plaque thicknesses and the presence of MRA
IHIS using the Student's t-test. We calculated the differences in sensitivity and specificity
measures of CTA and MRA source-imaging data with the occurrence of recent ipsilateral stroke or
transient ischemic attack (TIA) as the reference standard. We also performed logistic regression
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analyses to evaluate the predictive strength of plaque showing both IHIS and increased CTA soft
plaque thickness in predicting symptomatic disease status.

Author Manuscript

Results—Of 1994 screened patients, 48 arteries met the final inclusion criteria with MRA and
CTA performed within 10 days of one another. The mean and median time between CTA and
MRA exams were 2.0 days and 1 day, respectively. A total of 34 of 48 stenotic vessels (70.8%)
were responsible for giving rise to ipsilateral stroke or TIA. CTA mean soft plaque thickness was
significantly greater (4.47 vs. 2.30 mm, p < 0.0001) in patients with MRA-defined IHIS, while
CTA hard plaque thickness was significantly greater (2.09 vs. 1.16 mm, p = 0.0134) in patients
without MRA evidence of IHIS. CTA soft plaque thickness measurements were more sensitive
than MRA IHIS (91.2 vs. 67.6%, p=0.011) in detecting symptomatic plaque, while differences in
specificity were not significantly different (p = 0.1573). In the subset of patients with both IHIS on
MRA and plaque thickness >2.4 mm on CTA, the odds ratio of detecting symptomatic plaque,
corrected for stenosis severity, was 45.3 (p < 0.0005).
Conclusions—Unprocessed source images from CTA and MRA, which are routinely evaluated
for clinical studies demonstrate the highly correlated presence of IHIS and increasing soft plaque
thickness. In particular, plaque that shows high-risk features on both MRA and CTA are very
strongly associated with symptom-producing carotid plaque. With further validation, such
techniques are promising practical methods of extracting risk information from routine neck
angiographic imaging.
Keywords
Carotid artery stenosis; MRA; CTA; Stroke; TIA
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Introduction

Author Manuscript

Carotid artery atherosclerosis is responsible for up to 15% of strokes in the United States
and remains a significant public health burden [1]. Recent data suggest that the annual stroke
risk in asymptomatic carotid artery stenosis of ≥ 50% may be on the order of 1% [2, 3],
making luminal stenosis alone a relatively weak risk stratification tool. Such data illustrate
the need for more powerful techniques to identify vulnerable carotid artery plaque so that
the asymptomatic patients at the highest risk for stroke may be targeted with more
aggressive treatment, including surgical revascularization [4, 5]. Much of the recent
literature on imaging of carotid artery plaque has focused on multi-sequence carotid MRI,
given its ability to accurately differentiate between high-risk elements in atherosclerotic
plaque such as intraplaque hemorrhage, lipid-rich necrotic core, and thinning/rupture of the
fibrous cap [6, 7]. Despite these tissue-discrimination capabilities, such MRI techniques
have had only a limited impact on clinical care given the expense, time, and expertise
needed to perform high-quality dedicated multi-sequence MRI.
Recent investigations have focused on characterizing features of unstable plaque from
unprocessed MRA and CTA source images from which stenosis severity is already routinely
determined. Intraplaque high intensity signal (IHIS) can be determined on routinely acquired
axial 3D TOF MRA sources images as signal intensity >50% compared to the background
skeletal muscle, and has been studied as presumptive marker of intraplaque hemorrhage [8,
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9]. IHIS has been shown to be highly correlated with symptom-producing carotid artery
plaque after controlling for stenosis severity [8, 9]. Similarly, increasing thickness of low
attenuation soft plaque as measured on CTA neck source images has been shown to be
correlated with more advanced plaque as classified by multisequence carotid MRI [10] and
has been shown to be highly predictive of unstable plaque responsible for recent ipsilateral
ischemic symptoms [11, 12].

Author Manuscript

Given the widespread use of CTA and MRA in characterizing extracrancial carotid arterial
disease, it would be useful to understand the extent to which promising simple methods of
plaque imaging are correlated and can thereby identify the same high-risk tissue elements.
Similarly, it would be valuable to assess how a dual-modality assessment of carotid plaque
may improve the ability to predict the presence of high-risk, symptom-producing plaque.
Such an understanding is particularly valuable given the paucity of correlative
histopathologic data confirming the tissue types present in regions of IHIS on MRA and soft
plaque on CTA. Furthermore, such a comparison between plaque imaging modalities may
provide important data needed for future studies of comparative effectiveness of simple
plaque-imaging strategies in carotid disease. For these reasons, the purpose of our study was
threefold: (1) to evaluate the strength of correlation between IHIS on 3D-TOF MRA source
images and increasing soft plaque thickness on CTA; (2) to compare the sensitivity and
specificity of these techniques in identifying symptomatic carotid artery plaque, and (3) to
evaluate the predictive strength of a combined dual-modality assessment of plaque
composition on CTA and MRA in detecting symptom-producing plaque.

Methods
Subjects

Author Manuscript
Author Manuscript

Our Institutional Review Board approved this protocol. Potential subject records were
screened for this retrospective study via review of consecutive CTA neck examinations
performed between September 1, 2009 and March 1, 2014. This database of CTA neck
examinations is the same database of patients from which our group has previously
identified subjects to study CTA features of carotid plaque [11, 12]. However, the entirely
unique inclusion/exclusion criteria for the current study has resulted in a cohort distinct from
these prior studies with separate and new imaging analysis focused on both CTA and MRA
characteristics. Subject inclusion criteria included the following: (1) moderate-to high-grade
extracranial ICA stenosis (50–99%) identified on CTA neck examination as measured using
NASCET criteria in the original radiologic report; (2) sufficient documentation available in
the electronic medical records to confidently determine whether ipsilateral stroke or TIA had
occurred in the 30 days before the CTA so that patients could be labeled as either recently
symptomatic or asymptomatic (never symptomatic); (3) detailed medical record
documentation of pre-existing vascular risk factors; and (4) MRA with 3D-TOF imaging
performed within 10 days of the CTA examination. We applied the following exclusion
criteria: (1) patients with complete extracranial carotid occlusions; (2) patients with stroke or
TIA occurring greater than 30 days before the index CTA scan because these patients may
have experienced relevant changes of plaque morphology between ischemic symptom onset
and imaging; and (3) patients with non-diagnostic imaging in which a NASCET-style
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carotid artery stenosis measurement could not be provided during the initial clinical
interpretation secondary to reasons such as significant motion artifact or suboptimal contrast
enhancement of the arterial vasculature.
CTA Imaging Technique
The CTA neck exams in this study were performed using a standardized clinical protocol on
one of several scanners at our imaging sites including Lightspeed, Pro-16, or HD-750 (GE
Healthcare, Milwaukee, Wisconsin). Helical mode CT scanning was performed covering
from the aortic arch to the C1 ring. Collimation was performed at 0.625 mm, with a kVp of
120 and auto mA and a rotation time of 0.5 s. Approximately, 90 ml of nonionic iodinated
contrast (iohexol, Omnipaque, GE Healthcare, Inc.) was administered to each patient
through an 18-gauge peripheral IV at 4 to 5 ml/s using a power injector.

Author Manuscript

CTA Image Analysis

Author Manuscript

The details for CTA neck image analysis have been previously reported [10]. A boardcertified neuroradiologist analyzed axial source images from the CTA exam and recorded
three measurements: (1) NASCET stenosis measurements [13] using the normal distal
extracranial ICA as denominator for stenosis calculation, except in cases of near-occlusion
in which a stenosis value of 95% was assigned; (2) maximum thickness of the non-calcified,
soft plaque component on the single axial slice on which luminal diameter stenosis was
greatest; and (3) maximum thickness of the calcified, hard plaque component on the same
single axial slice on which luminal diameter stenosis was greatest. These measurements
were obtained on the axial slice with maximal luminal narrowing using the electronic caliper
on Centricity PACS (GE Healthcare, Milwaukee, Wisconsin), which allows measurements
to 0.1 mm. Window/level settings were set at approximately 800/200 with manual
adjustments permitted to optimize discrimination between soft and hard plaque, given the
inter-subject differences in contrast bolus timing and attenuation of the opacified, patent
lumen. The previously reported inter-observer reliability has been shown to be high with this
method with inter-reader correlation coefficients ranging from 0.91 to 0.97 for soft plaque
thickness measurements [10].
MRA Imaging Technique
MRA neck studies were performed on either 1.5T or 3.0T Signa (General Electric) scanners
using standard quadrature neck array coils. No dedicated high-resolution surface coils or
gadolinium was administered. 3D-TOF acquisition involved a 20-cm field-of-view centered
at the carotid bifurcation, 1.4 mm slice thickness, and a matrix of 320 × 192 and 320 × 224
on 1.5T and 3T, respectively.

Author Manuscript

MRA Imaging Analysis
IHIS, as a presumptive marker of IPH, was determined from a method first described by
Qiao et al. [9] and subsequently adapted for a subsequent study correlating plaque
characteristics with symptomatic disease status [8]. Briefly, a neuroradiologist assessed the
presence of hyperintense signal intensity on 3D-TOF source images using region-of-interest
analysis in carotid artery plaque relative to adjacent skeletal muscle (see fig. 1, 2). To ensure

Cerebrovasc Dis. Author manuscript; available in PMC 2016 February 02.

Gupta et al.

Page 5

Author Manuscript

that both CTA and MRA studies were being analyzed on a similar axial plane, the MRA
exam was evaluated for IHIS on the same craniocaudal level shown to have maximal
luminal stenosis on the CTA study. To evaluate the possibility that our single slice
evaluation technique may be falsely categorizing IHIS-negative studies, we reviewed the
entire MRA source image data set from a randomly selected subset of 10 subjects with IHISnegative plaque to evaluate the possibility that IHIS may have been present elsewhere over
the extent of the plaque. We used a quantitative cutoff of signal intensity 50% greater than
the sternocleidomastoid skeletal muscle based on the region-of-interest analysis of voxels
containing IHIS. A previous report of this specific technique's reproducibility has shown
inter-observer agreement rates of approximately 80% [8]. Similarly, in studies with
pathologic confirmation, diagnostic accuracy of 84% for intraplaque hemorrhage detection
was found using TOF source images with excellent intra- and inter-observer agreements
with Kappa values ranging from 0.77 to 0.84 [9].

Author Manuscript

Clinical Data Assessment

Author Manuscript

Two study investigators blinded to imaging data determined whether each patient was either
symptomatic or asymptomatic ipsilateral to the side of the index carotid artery. Symptomatic
disease was defined as prior ipsilateral TIA or stroke occurring before the MRA and CTA
exam. We used American Heart Association definitions of TIA and stroke [14], with a
stroke and TIA defined as a permanent or transient episode, respectively, of neurological
dysfunction caused by focal brain or retinal ischemia. We required that all strokes had either
MR or CT imaging confirmation. We classified stroke or TIA as being symptomatic disease
only when events were referable to the stenotic ICA. Days between qualifying ipsilateral
ischemic events and index CTA were calculated. Asymptomatic carotid disease was defined
as the absence of any prior history of stroke or TIA ipsilateral to the index carotid artery.
Any disagreements in data extraction including ischemic outcome adjudication were
resolved by consensus.
The same two investigators also collected preexisting vascular risk factors after a complete
examination of the electronic medical record. We recorded the presence of the following
risk factors: (1) a smoking history; (2) diabetes (a Hemoglobin A1C >6.5% or on diabetic
medication); (3) hypertension (blood pressure >140/90 or on antihypertensive medication);
(4) atrial fibrillation; (5) hyperlipidemia (LDL >100 or on statin); and (6) coronary artery
disease.
Statistical Analysis

Author Manuscript

Categorical variables are presented as n (%) and continuous variables as mean ± SD.
Differences between patient characteristics and clinical risk factors and the presence of
symptomatic versus asymptomatic plaque was evaluated with the Student's t-test or Chisquare test, where appropriate. We used the Student's t-test to determine whether the
presence or absence of IHIS on MRA was associated with differences in hard and soft
plaque thickness on CTA. We also performed a subset analysis stratified by magnet field
strength to determine whether the presumptive markers of vulnerable plaque (IHIS and soft
plaque) demonstrated a statistically significant relationship on both 1.5T and 3.0T platforms.
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In previous investigations [11, 12] soft plaque thickness measurements of 3.5 and 2.2 mm
were found to be the optimal cutoffs to predict the presence of symptomatic plaque in
patients with 70–99 and 50–69% ICA stenosis, respectively. Because of the possible
correlation between increasing stenosis severity and soft plaque thickness, we used these
stratified soft plaque thickness cutoffs in our analysis. We calculated operating
characteristics including sensitivity, specificity, PPV, NPV, and accuracy (defined as the
number of correct assessments out of all assessments) for detecting the presence of
symptomatic plaque using the following definitions of a positive test result: (1) on MRA, the
presence of IHIS for all stenosis severities was considered a positive test result; and (2) on
CTA, soft plaque thicknesses >3.5 mm in subjects with 70 to 99% stenosis and >2.2 mm in
50 to 69% stenosis were considered positive test results. We assessed whether there were
statistically significant differences in sensitivity and specificity between CTA soft plaque
measurements and MRA IHIS assessments for the diagnosis of symptomatic carotid artery
plaque using the McNemar's test for correlated proportions. We also calculated the odds
ratio expressing the association between hard plaque thickness, soft plaque thickness, and
the presence of IHIS in a univariate analysis and corrected for stenosis severity in a logistic
regression analysis. All p values are two-sided with statistical significance evaluated at the
0.05 alpha level. All analyses were performed using SAS 9.3 (SAS Institute, Cary, N.C.,
USA).

Author Manuscript
Results

Subject Characteristics
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We screened 1994 patients who had undergone CTA. We excluded 1,538 patients because
these subjects did not have ≥ 50–99% extracranial internal carotid artery stenosis and 79
because of complete carotid occlusion, leaving 183 of the original 1994 still potentially
eligible. Of these, 48 arteries met final inclusion criteria with MRA and CTA performed
within 10 days of one another. Five subjects had bilateral ICA disease eligible for analysis,
yielding a total of 43 unique subjects analyzed. The mean time and median time between
CTA and MRA exams were 2.0 days and 1 day, respectively. Clinical indications for CTA
and MRA included suspected stroke or TIA workup in 38 subjects (88.3%), further
characterization of known carotid stenosis without suspicion of recent ischemia in 4 subjects
(9.3%), and workup of incidentally detected carotid disease detected on other brain and neck
imaging in 1 subject (2.3%).

Author Manuscript

A total of 34 of 48 vessels studied (70.8%) were from patients who had ischemic symptoms
ipsilateral to the side of moderate-or high-grade carotid stenosis. Among the cerebrovascular
events that had occurred, 30 had ipsilateral strokes and 4 had ipsilateral TIAs. All strokes
had CT or MR imaging confirmation demonstrating infarction. All recorded ischemic events
occurred within 30 days preceding the CTA index imaging study. The mean and median
time between CTA imaging and the ipsilateral ischemic events were 3 days and 0 day,
respectively. Patient risk factor and demographic characteristics are shown in table 1. There
was a statistically significant difference in the degree of stenosis between symptomatic and
asymptomatic subjects. The remaining risk factors were not significantly different between
groups.
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There were statistically significant differences in CTA plaque thickness measures in patients
with and without MRA defined IHIS (table 2). CTA mean soft plaque thickness was
significantly greater (4.47 vs. 2.27 mm, p < 0.0001) in patients with MRA-defined IHIS,
while CTA hard plaque thickness was significantly greater (2.14 vs. 1.16 mm, p = 0.0073) in
patients without MRA evidence of IHIS. The association between the presumptive high-risk
markers of CTA soft plaque thickness and MRA IHIS was preserved in subset analyses
across 1.5T and 3.0T magnet field strengths (table 3). In the subset of 10 randomly selected
subjects deemed to have IHIS-negative MRA on the axial slice of greatest luminal stenosis,
full evaluation of the plaque extent in these patients revealed no evidence of IHIS over the
entire length of the carotid artery plaque.

Author Manuscript

The presence of IHIS and increasing soft plaque thickness were both predictive of
symptomatic status, while the presence of increasing hard plaque thickness was associated
with asymptomatic plaque (table 4). We had 22 subjects with soft plaque >2.4 mm and the
presence of IHIS; conversely, we had 12 subjects with soft plaque <2.4 mm and the absence
of IHIS. The presence of both IHIS on MRA and >2.4 mm soft plaque thickness conferred
the greatest predictive strength for symptomatic plaque, with an OR of 45.3 (95% CI 5.2–
392.3) after correction for differences in stenosis. Similarly, the absence of IHIS and soft
plaque thickness <2.4 mm was very strongly associated with the lack of recent ipsilateral
stroke or TIA with an OR of 0.022 (95% CI 0.003–0.191) after correction for differences in
stenosis.
Diagnostic Accuracy of MRA and CTA in Detecting Symptomatic Plaque

Author Manuscript

We found that dichotomized CTA soft plaque thickness (2.2 mm for 50–69% and 3.5 mm
for 70–99%) was a more accurate marker of recently symptomatic plaque than MRA IHIS in
both the moderate (accuracy of 82.6 vs. 69.6%) and high-grade stenosis categories (accuracy
84.0 vs. 68.0%) (table 4). When using a single optimal threshold value of 2.4 mm of soft
plaque derived from the cohort in this study, soft plaque measurements also demonstrated
greater diagnostic accuracy (91.2 vs. 67.6%) (table 5). Moreover, McNemar's test for
correlated proportions demonstrated that CTA soft plaque thickness measurements were
more sensitive than MRA IHIS (91.2 vs. 67.6%, p = 0.011) in detecting symptomatic
plaque, while differences in specificity (85.7% for CTA soft plaque vs. 71.4% for MRA
IHIS) were not statistically significant (p = 0.1573).

Discussion
Author Manuscript

By using only the unprocessed source data from CTA and MRA imaging of carotid artery
stenosis, we found that increasing CTA soft plaque thickness measurements were strongly
associated with the presence of IHIS on MRA source images. Moreover, using the presence
of symptomatic plaque as a reference standard, we found a statistically and significantly
higher sensitivity of CTA soft plaque measurements compared to MRA IHIS. Perhaps of
greatest interest, we found that a dual-modality assessment of carotid plaque may identity
those plaques most likely to be symptom-producing, as plaques with both IHIS on MRA and
soft plaque thickness of greater than 2.4 mm were very strongly associated with recent
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ipsilateral stroke or TIA. Unlike other studies evaluating the correlation between high-risk
plaque features on MRI and CTA [9, 10], ours was the first study to use MRI techniques
without gadolinium, a carotid coil, or any imaging sequences beyond those needed for a 3DTOF acquisition. Similarly, CTA exams were done using a routine standard of care clinical
protocol and all image analysis was performed without additional post-processing or
specialized software.

Author Manuscript
Author Manuscript

The high correlation between IHIS and plaque soft thickness measurements on CTA may be
related to the imaging appearance of lipid or hemorrhage known to be present in vulnerable
atherosclerotic plaque. Recent pooled data from prospective observational studies of carotid
stenosis patients after carotid plaque MRI demonstrates that intraplaque hemorrhage and
lipid-rich necrotic core are two important tissue types that can confer a 3- to 6-fold increased
risk of ischemic events for a given degree of stenosis [6]. It is likely that the areas of low
plaque attenuation on CT and areas of bright signal on MR represent varying degrees of
lipid-rich necrotic core and intraplaque hemorrhage and may therefore represent simple
composite imaging markers of these relatively high-risk atherosclerotic plaque elements.
The precise differentiation between lipid and hemorrhage in these plaques is likely not
possible on CTA or MRA source images alone. Hounsfield unit attenuation measurements
have historically shown a poor ability to discriminate [15–18] between specific tissue types
in advanced atherosclerotic plaque. Similarly, without a dedicated multisequence protocol or
a carotid coil, there will likely be similar limitations on the accuracy of 3D-TOF MRA
images in differentiating tissue elements which cause T1-shortening, such as lipid or
methemoglobin within intraplaque hemorrhage [8]. However, given the relatively similar
stroke risk conferred by the presence of plaque hemorrhage and lipid-core, the clinical value
of differentiating these tissue types may be limited. Ultrasound data also support this
approach of using a simplified marker of risk rather than using imaging to differentiate
between tissue histologies, as several investigations have shown echolucent plaque [19–21]
to be a high-risk marker of carotid stenosis more likely to cause symptoms than
predominantly echogenic plaque.

Author Manuscript

The presence of increasing hard plaque thicknesses on CTA was associated with the absence
of IHIS on MRA. The physical basis of this finding likely is related to the marked
hypointensity generally seen with dense calcification on MRI images. As prior reports
including a systematic review of the role of calcium deposition in carotid plaque stability
have suggested [22, 23], increasing volumes of calcium in carotid atherosclerosis likely
indicate relative plaque stability for a given degree of stenosis. The mechanism by which
calcium may improve plaque stability requires further elucidation, but may in part be related
to the greater mechanical stability afforded by calcium deposition or relatively
antithrombotic property of calcified plaque compared to soft tissue plaque [24].
Alternatively, it could be the case that plaque calcification plays little role in plaque stability
but may instead represent an epiphenomenon seen only in plaque stable long enough to
allow for the physiologic deposition of calcium. Since the detection of calcium is most
easily made on CT, the absence of IHIS or MRA is likely not an accurate indicator of
relatively stable carotid plaque as has been suggested with increasing hard plaque thickness
on CTA.
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In our study, we also demonstrated that CTA soft plaque thickness demonstrated
significantly higher sensitivity for the detection of symptomatic plaque. Though the ultimate
validation of these methods will be the prediction of future ischemic events, our data is still
informative, as it gives us insight into the potential relative comparative accuracy of simple
plaque imaging techniques. MRA-based IHIS determination is dichotomous, while CTA
plaque thickness measurements are potentially more informative as continuous variables,
which can allow for specific positivity thresholds depending on the severity of stenosis.
Moreover, the significantly higher spatial resolution of CTA source images compared with
3D-TOF MRA imaging obtained without a dedicated carotid coil may also explain the
relatively higher reproducibility measures seen in previous reports of these CTA techniques
[10]. Speed and accessibility in the acute setting are additional benefits of the CTA imaging
strategy. Nonetheless, the optimal simple plaque imaging strategy (including possibly a dual
or multi-modality approach) will require further study, as MRA has several factors in its
favor including potentially more valuable brain imaging information from concurrently
acquired brain MRI, the lack of ionizing radiation, and no need for intravenous contrast
administration.

Author Manuscript
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We believe that our current study adds two main important advances in our understanding
carotid artery disease. First, this study shows that high-risk features of carotid plaque are
evident using standard cross-sectional imaging techniques on both MRI and CT without
advanced imaging equipment. Though there are several papers showing the value of source
MRA [9, 25, 26] and CTA imaging [17, 18, 27–30] in carotid plaque, the correlation
between these commonly acquired imaging tests has not been studied formally. The high
correlation between IHIS on MRA and soft plaque on CTA suggests that there is significant
overlap in the appearance of vulnerable atherosclerotic elements across modalities. Though
multi-sequence MRI of carotid plaque with a dedicated carotid coil has provided a
tremendous improvement in our understanding human atherosclerosis, we believe that the
challenges of performing this technique in clinical practice make the simple markers of
plaque vulnerability described in this study attractive imaging biomarkers for stroke risk
prediction. Second, given the decreasing risk of annual stroke in asymptomatic carotid
stenosis [3, 31], single risk markers may not be sufficient to identify those patients at highest
risk of stroke and therefore may be inadequate as a tool to inform decisions to pursue
surgical revascularization [32, 33]. Toward this end, our study has identified a new potential
dual-modality marker of high-risk plaque (the composite presence of IHIS on MRA and soft
plaque thickness of greater than 2.4 mm), which now warrants investigation in prospective
studies. With further validation, these simple source image strategies for stroke risk
stratification may allow us to obtain detailed plaque characteristics and quantitative brain
hemodynamics in the same imaging platform, thereby creating an opportunity for an
integrated pathophysiologic approach [34] to stroke risk stratification in carotid stenosis. Todate, such an integrated hemodynamic and plaque vulnerability risk assessment approach
has been difficult to implement alongside lengthy multi-sequence carotid plaque imaging
techniques.
Our study has several limitations. First, in this study, we retrospectively correlated plaque
characteristics with recent ischemic events that occurred prior to CT or MR imaging.
Prospective validation in a longitudinal cohort is needed to validate these techniques as riskCerebrovasc Dis. Author manuscript; available in PMC 2016 February 02.
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stratification techniques. However, given the converging evidence [6] confirming the
prediction power of intraplaque hemorrhage and lipid-rich necrotic core, we hypothesize
that the presumptive risk-markers studied would likely function similarly in predicting
future events. Second, since atherosclerosis is a dynamic process, it is possible that the
plaque elements we studied evolved between the time of the CTA and MRA exam. We
minimized this risk by limiting our study only to those cases in which CTA and MRA were
done within 10 days of one another with the mean time between imaging studies closer to 2
days in our study. Moreover, longitudinal MRI data of carotid plaque suggests that high-risk
elements such as plaque hemorrhage do not change significantly over a 1-year follow-up
period and can predict stroke risk for at least 5 years in prospective observational studies
[35, 36]. Third, we focused on detecting IHIS on a single slice shown to have maximal
luminal stenosis on CTA, and we thereby may have not detected IHIS proximal or distal to
the site of maximum stenosis. Such an approach, we believe, however, was necessary to
closely co-register images and best allow us to evaluate the same tissue across modalities
and explore the hypothesis that CT and MRI source-imaging data may contain similar
plaque vulnerability information. Furthermore, in our subset of randomly selected IHISnegative patients, we found that a full evaluation of the plaque extent in these patients
revealed no evidence of IHIS over the entire length of the carotid artery plaque, suggesting
that analyzing images at the level of maximal stenosis may be a reasonable approach to
identify the presence of high-risk plaque elements within a given carotid plaque. Fourth, our
study lacked histopathologic confirmation of the substrate composing IHIS on MRA and
soft plaque on CTA. Despite this, there is strong evidence from existing histopathologic
studies [26] suggesting that our presumptive imaging biomarkers likely represent varying
degrees of intraplaque hemorrhage and lipid-rich necrotic core. We do agree that correlation
with carotid endarterectomy specimens would be informative to enhance our understanding
of the pathophysiologic features captured by these imaging strategies. Fifth, given the
predominance of CT and MR performed in our local practice for the work up of suspected
TIA or stroke, we lacked ultrasound plaque data on these patients which will be important to
include in future multi-modality investigations of high-risk plaque features. In addition to
characterizing simple high-risk features of plaque composition such as echolucency,
ultrasound is also valuable, as it can provide insight into local flow hemodynamics, which is
typically not available from the structural data present on MRA and CTA.

Conclusions
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In conclusion, in this correlative study we were able to demonstrate a strong association
between markers of presumed high-risk plaque on both CTA and MRA, and showed that
CTA soft plaque measurements were more sensitive than MRA IHIS in diagnosing the
presence of symptomatic plaque. Most importantly, plaque that showed high-risk features on
both CTA and MRA were the most strongly predictive of symptomatic plaque. Further
assessment of these simple CT and MRA measures of high-risk plaque, including in a
combined approach, are now warranted in appropriately powered prospective outcome
studies.
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Fig. 1.

Author Manuscript

a Magnified axial CTA image of the proximal left internal carotid artery in a representative
subject. Black arrow represents the residual patent ICA lumen. The white calipers represent
maximum linear soft plaque thickness and black calipers represent maximum hard plaque
thickness measurement. b Correlative 3D-TOF source MRA image for the same subject
shown in (a). Patient lumen shown with the white arrow and area of IHIS is shown with the
black arrow. c Larger field-of view image showing both ICAs on the same CTA source
image shown in detail in (a). d Larger field-of-view image showing both ICAs on the same
MRA source image shown in detail in (b).
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Fig. 2.

a Representative magnified axial CTA image of the proximal left internal carotid artery in a
subject with predominantly soft plaque. White arrow represents the residual patent ICA
lumen. The white calipers represent maximum linear soft plaque thickness. This subject has
no discernable hard plaque at this level. b Correlative 3D-TOF source MRA image for the
same subject shown in (a). Patient lumen shown with the white arrow and area of IHIS is
shown with the black arrow. c Larger field-of view image showing both ICAs on the same
CTA source image shown in detail in (a). d Larger field-of-view image showing both ICAs
on the same MRA source image shown in detail in (b).
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Table 1
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Cohort demographics and risk factor differences between main study groups
Symptoms
Patient characteristics and risk factors

Overall (n = 48)

p value
yes (n = 34)

no (n = 14)

Age, mean (years)

74.5±9.8

74.5±10.2

74.4±9.0

0.9639

Sex, male

28 (58.3)

21 (61.8)

7 (50.0)

0.4524

Stenosis, %

72.9±15.0

76.7±14.9

63.8±11.0

0.0055

Hypertension

41 (85.4)

29 (85.3)

12 (85.7)

1.0000

Diabetes

13 (27.1)

10 (29.4)

3 (21.4)

0.7279

Hyperlipidemia

35 (72.9)

25 (73.5)

10 (71.4)

1.0000

A-fib

10 (20.8)

6 (17.7)

4 (28.6)

0.4480

CAD

5 (10.4)

4 (11.8)

1 (7.1)

1.0000

Smoking history
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29 (60.4)

21 (61.8)

8 (57.1)

1.0000

Heart failure

3 (6.3)

1 (2.9)

2 (14.3)

0.1999

COPD

3 (6.3)

2 (5.9)

1 (7.1)

1.0000

CKD

1 (2.1)

0 (0)

1 (7.1)

0.2917

Mean values are shown with the number of subjects shown in parenthesis and standard deviations shown after ± signs.
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Correlation between the presence of MRA IHIS and CTA plaque thickness measurements
MRA IHIS present?
p value
yes (n = 27)

no (n = 21)

CTA soft plaque thickness, mm

4.47±1.41

2.3±1.58

<0.0001

CTA hard plaque thickness, mm

1.16±1.14

2.09±1.36

0.0134
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Correlation between the presence of MRA IHIS stratified by magnet field strength and CTA soft plaque
thickness measurements
MRA IHIS present?
p value
yes

no

Studied on 1.5T MRI

(n = 15)

(n = 10)

    CTA soft plaque thickness, mm

4.53±1.66

2.84±1.84

Studied on 3T MRI

(n = 12)

(n = 11)

    CTA soft plaque thickness, mm

4.39±1.07

1.83±1.20

0.0261

<0.0001

Author Manuscript
Author Manuscript
Author Manuscript
Cerebrovasc Dis. Author manuscript; available in PMC 2016 February 02.

Gupta et al.

Page 19

Table 4
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Univariate and Multivariate logistic regression analyses showing the association (odds ratio) between each
imaging marker and the risk of ipsilateral symptomatic disease
Univariate

CTA hard plaque thickness (per 1 mm increase)
CTA soft plaque thickness (per 1 mm increase)

Multivariate

*

OR (95% CI)

p value

OR (95% CI)

p value

0.23 (0.09–0.60)

0.0028

0.26 (0.10–0.67)

0.0055

2.76 (l.52–5.04)

0.0009

2.42 (1.30–4.53)

0.0055

5.23 (1.34–20.45)

0.0175

6.67 (1.42–31.26)

0.0160

Soft plaque >2.4 mm and presence of IHIS

55.0 (6.8–448.1)

0.0002

45.3 (5.2–392.3)

0.0005

Soft plaque <2.4 mm and absence of IHIS

0.018 (0.002–0.148)

0.0002

0.022 (0.003–0.191)

0.0005

MRA presence of IHIS

*

Adjusted for stenosis (%).
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Table 5
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Diagnostic operating characteristics for CTA plaque thickness measurements and MRA IHIS
Diagnostic accuracy

n

Sensitivity (95% CI)

Specificity (95% CI)

PPV (95% CI)

NPV (95% CI)

Accuracy (95% CI)

Overall

48
91.2 (76.3–98.1)

85.7 (57.2–98.2)

93.9 (79.8–99.3)

80.0 (51.9–95.7)

89.6 (77.3–96.5)

67.6 (49.5–82.6)

71.4 (41.9–91.6)

85.2 (66.3–95.8)

47.6 (25.7–70.2)

68.8 (53.7–81.3)

    Soft (2.2 mm
threshold)

91.7 (61.5–99.8)

72.7 (39.0–94.0)

78.6 (49.2–95.3)

88.9 (51.8–99.7)

82.6 (61.2–95.0)

    IHIS

75.0 (42.8–94.5)

63.6 (30.8–89.1)

69.2 (38.6–90.9)

70.0 (34.8–93.3)

69.6 (47.1–86.8)

81.8 (59.7–94.8)

100.0 (29.2–100.0)

100.0 (81.5–100.0)

42.9 (9.9–81.6)

84.0 (63.9–95.5)

63.6 (40.7–82.8)

100.0 (29.2–100.0)

100.0 (76.8–100.0)

27.3 (6.0–61.0)

68.0 (46.5–85.1)

91.7 (73.0–99.0)

83.3 (51.6–97.9)

91.7 (73.0–99.0)

83.3 (51.6–97.9)

88.9 (73.9–96.9)

    Soft (2.4 mm
threshold)
    IHIS
50–69% stenosis

70–99% stenosis

23

25

    Soft (3.5 mm
threshold)
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    IHIS
Soft (2.4 mm) and
IHIS

36

All values shown in the table expressed as percentages.
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